The Effect of Different Food Products on Post Prandial Blood Glucose in Pregnant Woman With Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02154997|
Recruitment Status : Unknown
Verified February 2016 by Uri Elchalal, Hadassah Medical Organization.
Recruitment status was: Recruiting
First Posted : June 4, 2014
Last Update Posted : March 1, 2016
During pregnancy nutrition demands change and the pregnant woman needs to adjust her food intake and take into consideration the corrected daily recommendations for micro and macro nutrients. Pregnant woman tend to suffer from hyperemesis and this affects their food choice.
Amongst pregnant women with Diabetes the glucose balance is extremely important during pregnancy. Glucose balance is a result of correct nutrition and an exact amount of insulin. This delicate balance requires from the pregnant women an ability to perform correct carbohydrate count.
Hyperglycemia has already been proven to affect the fetus and the neonatal outcomes. Hypoglycemia may also have a negative effect but the main danger is immediate harm to the mother and therefore to the fetus. For those reasons glucose balance is crucial and demands delicate synchronization of nutrition and insulin therapy.
|Condition or disease|
|Type 1 Diabetes Type 2 Diabetes Gestational Diabetes|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Observational Model:||Case Control|
|Study Start Date :||November 2014|
|Estimated Primary Completion Date :||June 2017|
|Estimated Study Completion Date :||December 2017|
Type 1 and Type 2 Diabetes
pregnant women which have a known condition of type 1 or type 2 diabetes
pregnant women which have developed Gestational diabetes
Pregnant women whom do not suffer from any altered glucose metabolism
- Post prandial blood glucose levels [ Time Frame: The outcome will be measured at various time points during a 120 min OGTT: Fasting, 30, 60, 90 and 120 min ]For every time point blood glucose will be analyzed for blood glucose and for Insulin and C-peptide for the control group
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02154997
|Contact: Uriel Elchalal, MDemail@example.com|
|Hadassah Ein Kerem||Recruiting|
|Jerusalem, Israel, 91120|
|Contact: Uriel Elchalal, MD firstname.lastname@example.org|
|Principal Investigator:||Ram Weiss, Md PhD||Hebrew Universtity|
|Principal Investigator:||Karen J Hershkop, PhD||Hebrew University|
|Principal Investigator:||Limor Marko, MSc||Hebrew University|